Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 64 | BES2019 | Next issue

Belgian Endocrine Society 2019

BES 2019

Severe hypocalcemia after a single denosumab injection and tumor-induced persistent hypophosphatemia in a patient with metastatic prostate cancer

ea0064039 | Severe hypocalcemia after a single denosumab injection and tumor-induced persistent hypophosphatemia in a patient with metastatic prostate cancer | BES2019

Severe hypocalcemia after a single denosumab injection and tumor-induced persistent hypophosphatemia in a patient with metastatic prostate cancer

Aude Theunissen , Thierry Roumeguere , Bernard Corvilain , Aglaia Kyrilli

Case report: A 81-year-old male patient suffering from a Gleason 9 pT3aN0M0R1 prostatic adenocarcinoma was treated with radical prostatectomy and adjuvant radiotherapy in 2014. He presented in outpatient clinic for lumbar pain in October 2018. A 18F-NaF PET/CT showed diffuse metastatic bone involvement. Laboratory results showed hypophosphatemia (0.52 mmol/L, N: 0.75–1.39), normal renal function, normocalcemia (2.35 mmol/L, N: 2.20–2.55), normal 25-OH vitamin D (36 μg/L, N: 30...